Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role.

PubWeight™: 1.33‹?› | Rank: Top 10%

🔗 View Article (PMC 112049)

Published in J Virol on June 01, 2000

Authors

M K Hasan1, A Kato, M Muranaka, R Yamaguchi, Y Sakai, I Hatano, M Tashiro, Y Nagai

Author Affiliations

1: Department of Viral Diseases and Vaccine Control, National Institute of Infectious Diseases, Tokyo 208-0011, Japan.

Articles citing this

AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol (2005) 1.44

Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44

Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol (2001) 1.39

C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein. J Virol (2002) 1.38

Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32

Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol (2001) 1.32

Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function. J Virol (2004) 1.21

Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol (2005) 1.17

Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J Virol (2008) 1.16

Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J Virol (2004) 1.15

Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol (2007) 1.09

Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates. J Virol (2008) 1.03

Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner. J Virol (2003) 1.03

The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis. J Virol (2002) 0.98

The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS One (2010) 0.92

The C-terminal end of parainfluenza virus 5 NP protein is important for virus-like particle production and M-NP protein interaction. J Virol (2010) 0.90

Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses. PLoS One (2010) 0.89

Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence. J Virol (2012) 0.88

The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection. J Virol (2008) 0.88

The C proteins of human parainfluenza virus type 1 block IFN signaling by binding and retaining Stat1 in perinuclear aggregates at the late endosome. PLoS One (2012) 0.83

Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells. Proc Natl Acad Sci U S A (2011) 0.82

Sendai virus C proteins regulate viral genome and antigenome synthesis to dictate the negative genome polarity. J Virol (2013) 0.81

Antagonism of innate immunity by paramyxovirus accessory proteins. Viruses (2009) 0.81

Clustered basic amino acids of the small sendai virus C protein Y1 are critical to its RAN GTPase-mediated nuclear localization. PLoS One (2013) 0.80

Passage of a Sendai virus recombinant in embryonated chicken eggs leads to markedly rapid accumulation of U-to-C transitions in a limited region of the viral genome. PLoS One (2012) 0.80

A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates. Vaccine (2009) 0.79

Identification of a mutation in editing of defective Newcastle disease virus recombinants that modulates P-gene mRNA editing and restores virus replication and pathogenicity in chicken embryos. J Virol (2003) 0.78

Studies on the paramyxovirus accessory genes by reverse genetics in the Sendai virus-mouse system. Proc Jpn Acad Ser B Phys Biol Sci (2008) 0.78

N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication. Virology (2009) 0.77

Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein. J Virol (2015) 0.76

Viral protein requirements for assembly and release of human parainfluenza virus type 3 virus-like particles. J Gen Virol (2016) 0.75

Evidence for phosphorylation of human parainfluenza virus type 3 C protein: mutant C proteins exhibit variable inhibitory activities in vitro. Virus Res (2009) 0.75

Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs. PLoS One (2016) 0.75

Articles cited by this

Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85

Budding of rabies virus particles in the absence of the spike glycoprotein. Cell (1996) 4.46

Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology (1991) 4.45

The budding mechanisms of enveloped animal viruses. J Gen Virol (1980) 4.08

Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41

Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J (1988) 3.33

Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23

Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol (1999) 2.99

Interferon-induced proteins and the antiviral state. Adv Virus Res (1990) 2.84

The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J (1991) 2.83

HIV accessory proteins: leading roles for the supporting cast. Cell (1995) 2.82

The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71

Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53

Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol (1999) 2.51

Interferon-induced antiviral actions and their regulation. Adv Virus Res (1993) 2.40

The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology (1992) 2.17

The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol (1996) 1.94

ACG, the initiator codon for a Sendai virus protein. J Biol Chem (1988) 1.94

Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett (1999) 1.92

Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology (1976) 1.81

Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells (1998) 1.62

Sendai virus M protein binds independently to either the F or the HN glycoprotein in vivo. J Virol (1994) 1.61

Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol (1997) 1.59

Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol (1997) 1.58

A small highly basic protein is encoded in overlapping frame within the P gene of vesicular stomatitis virus. J Virol (1993) 1.58

Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO J (1989) 1.54

Studies on the assembly of the envelope of Newcastle disease virus. Virology (1976) 1.54

Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol (1998) 1.50

Studies on the role of M protein in virus assembly using a ts mutant of HVJ (Sendai virus). Virology (1979) 1.42

The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology (1997) 1.41

Paramyxovirus reverse genetics is coming of age. Microbiol Immunol (1999) 1.37

Isolation and characterization of two distinct types of HVJ (Sendai virus) spikes. Virology (1974) 1.36

Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology (1990) 1.30

Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev Med Virol (1999) 1.28

Localization and characterization of Sendai virus nonstructural C and C' proteins by antibodies against synthetic peptides. Virus Res (1986) 1.24

Sendai virus P gene produces multiple proteins from overlapping open reading frames. Enzyme (1990) 1.18

The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides. Virology (1977) 1.14

Assembly of nucleocapsids with cytosolic and membrane-derived matrix proteins of vesicular stomatitis virus. Virology (1999) 1.06

Association of the Sendai virus C protein with nucleocapsids. Arch Virol (1990) 1.05

Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames. J Virol (1994) 1.01

Replication-incompetent Sendai virus can suppress the antiviral action of type I interferon. Arch Virol (1999) 0.94

Subcellular location of the major protein antigens of paramyxoviruses revealed by immunoperoxidase cytochemistry. Microbiol Immunol (1983) 0.87

Articles by these authors

The complete nucleotide sequence of the tobacco chloroplast genome: its gene organization and expression. EMBO J (1986) 19.59

Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med (1999) 9.23

The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med (2001) 7.49

Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1. DNA Res (1999) 7.39

Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79

Fetal growth and perinatal viability in California. Obstet Gynecol (1982) 5.23

Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology (1976) 4.85

Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill (2013) 4.44

Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen. J Bacteriol (1988) 3.97

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother (2003) 3.90

Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med (2000) 3.74

Tadpole collagenase. Preparation and purification. Biochemistry (1966) 3.50

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41

In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol (1981) 3.34

Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer (1983) 3.28

A glycolipid on the surface of mouse natural killer cells. Eur J Immunol (1980) 3.13

Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol (2000) 3.10

Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet (1999) 3.07

p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J (1993) 3.06

Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99

Automated analysis of protein NMR assignments using methods from artificial intelligence. J Mol Biol (1997) 2.86

The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71

Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci U S A (1965) 2.61

Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55

Nucleotide sequence of the PR-1 gene of Nicotiana tabacum. FEBS Lett (1987) 2.53

Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology (1983) 2.53

Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology (1987) 2.46

A woman who trembled, then had chorea. Lancet (1998) 2.40

Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology (2000) 2.37

Structure, chromosomal locus, and promoter analysis of the gene encoding the mouse helix-loop-helix factor HES-1. Negative autoregulation through the multiple N box elements. J Biol Chem (1994) 2.26

Regulation of the Escherichia coli hfq gene encoding the host factor for phage Q beta. J Bacteriol (1994) 2.26

Recovery of pathogenic measles virus from cloned cDNA. J Virol (2000) 2.19

Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17

Late thoracic outlet syndrome secondary to malunion of the fractured clavicle: case report and review of the literature. J Trauma (2001) 2.14

Six chloroplast genes (ndhA-F) homologous to human mitochondrial genes encoding components of the respiratory chain NADH dehydrogenase are actively expressed: determination of the splice sites in ndhA and ndhB pre-mRNAs. Mol Gen Genet (1987) 2.14

Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem (1992) 2.13

PAR-6 regulates aPKC activity in a novel way and mediates cell-cell contact-induced formation of the epithelial junctional complex. Genes Cells (2001) 2.13

Buoyancy and maximal diving depth in penguins: do they control inhaling air volume? J Exp Biol (2002) 2.12

Nucleotide sequences of tobacco chloroplast genes for elongator tRNAMet and tRNAVal (UAC): the tRNAVal (UAC) gene contains a long intron. Nucleic Acids Res (1982) 2.11

Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii. Infect Immun (1990) 2.06

Overlap and cotranscription of the genes for the beta and epsilon subunits of tobacco chloroplast ATPase. Gene (1983) 2.03

Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology (1977) 2.00

INE: a rice genome database with an integrated map view. Nucleic Acids Res (2000) 2.00

Therapeutic abortions in California. Calif Med (1971) 1.98

Role of Staphylococcus protease in the development of influenza pneumonia. Nature (1987) 1.96

New simple technique for hepatic parenchymal resection using a Cavitron Ultrasonic Surgical Aspirator and bipolar cautery equipped with a channel for water dripping. World J Surg (1999) 1.96

Topology and subcellular localization of FtsH protein in Escherichia coli. J Bacteriol (1993) 1.93

Inner-arm dynein c of Chlamydomonas flagella is a single-headed processive motor. Nature (1999) 1.92

Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. FEBS Lett (1999) 1.92

A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol (2000) 1.92

Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol (1992) 1.91

Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol (1993) 1.90

Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89

The nucleotide sequences of two tRNAAsn genes from tobacco chloroplasts. Nucleic Acids Res (1981) 1.84

Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3 (supplement). DNA Res (1998) 1.81

Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol (1986) 1.80

Two-step regulation of left-right asymmetric expression of Pitx2: initiation by nodal signaling and maintenance by Nkx2. Mol Cell (2001) 1.77

Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood (2000) 1.76

A rapid and micro method for separation of acidic glycosaminoglycans by two-dimensional electrophoresis. Anal Biochem (1972) 1.76

Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology (1993) 1.76

Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71

The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med (2000) 1.71

Characterization of a human H9N2 influenza virus isolated in Hong Kong. Vaccine (2001) 1.71

Monitoring perinatal mortality rates: California, 1970 to 1976. Am J Obstet Gynecol (1980) 1.70

Isolation and characterization of a rice cDNA which encodes a ubiquitin protein and a 52 amino acid extension protein. Plant Mol Biol (1993) 1.67

Isolation of chicken vasa homolog gene and tracing the origin of primordial germ cells. Development (2000) 1.67

An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J (1990) 1.66

Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol (1999) 1.66

Determining optimum fluoride levels for community water supplies in relation to temperature. J Am Dent Assoc (1967) 1.64

Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology (1989) 1.64

Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62

New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med (1999) 1.62

Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells (1998) 1.62

Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol (2001) 1.62

Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N Engl J Med (1981) 1.61

Isolation and properties of human blood-group NN and meconium-Vg antigens. Biochemistry (1966) 1.61

Nucleotide sequences of the 5.8S rRNA gene and internal transcribed spacer regions in carrot and broad bean ribosomal DNA. J Mol Evol (1989) 1.61

Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology (1993) 1.60

Mechanical compression of the extracranial vertebral artery during neck rotation. Neurology (2003) 1.59

Studies on the structure of collagen utilizing a collagenolytic enzyme from tadpole. Biochemistry (1966) 1.59

Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol (1997) 1.58

Purification and molecular structure of RNA polymerase from influenza virus A/PR8. J Biochem (1990) 1.57

Detection of significant bacteriuria by automated urinalysis using flow cytometry. J Clin Microbiol (2000) 1.56

Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett (1996) 1.56

Induction of aquaporin-4 water channel mRNA after focal cerebral ischemia in rat. Brain Res Mol Brain Res (2000) 1.56

Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis (1985) 1.55

Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology (1989) 1.55

Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol (2000) 1.55

Thallium-201 SPECT of adjacent intracranial tumours: a contrast in thallium kinetics. Neuroradiology (1999) 1.55

Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem (2001) 1.55